These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip? Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026. Barchart · Jan 29
6 Medicare Providers Dropping Out of Networks For millions of seniors, the promise of Medicare Advantage (Part C) was simple: lower premiums in exchange for staying within a network. In 2026, that... Saving Advice · Jan 26
We must not let AI ‘pull the doctor out of the visit’ for low-income patients Generative AI is being pushed into healthcare – and diagnostic risks may deepen the class divide The Guardian - US · Jan 25
What to Expect From Humana’s Next Quarterly Earnings Report Humana has scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a significant loss. Barchart · Jan 19
Medicare “Carrier Contraction”: Why UnitedHealthcare and Humana Just Exited 400+ Counties If you’ve ever told yourself Medicare Advantage “doesn’t really change,” 2026 is here to challenge that idea. In a lot of places, plan choices are... Saving Advice · Jan 16
AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors We hope 2026 is calmer after tariffs, public health chaos, and the cancellation of billions of research funding and health coverage support for millions. Fortune · Dec 9, 2025
Humana Stock Is Nearly 20% Off Its YTD Highs. Can Mark Cuban Change That? Mark Cuban is allegedly looking to partner with Humana on pharmacy offerings. Barchart · Dec 8, 2025
How Is Humana Stock Performance Compared to Other Healthcare Services Stocks? Humana stock has underperformed compared to the healthcare services group, but analysts remain fairly bullish about its prospects. Barchart · Dec 4, 2025
As Trump Calls Insurers ‘BIG,’ ‘BAD,’ and ‘Money Sucking,’ How Should You Play UnitedHealth Stock? UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story. Barchart · Nov 12, 2025
Humana CEO is betting on culture change and AI to fuel a turnaround Also: All the news and watercooler chat from Fortune. Fortune · Nov 10, 2025
From the Peace Corps to the boardroom: Humana CEO Jim Rechtin on listening and leading In a conversation with Fortune, Rechtin said the health-insurance giant that primarily serves seniors is "not where we want to be." Fortune · Nov 10, 2025
Continental thrift: five of the best cities in Europe for vintage shopping From flea markets in Berlin to thrift stores in Athens, a vintage shopping veteran picks her favourite places to shop for preloved bargains and unique souvenirs The Guardian - UK · Nov 9, 2025
Humana Q3 Premium Growth Offsets Membership Drop, Stock Tumbles Humana Inc. (NYSE:HUM) released its third-quarter earnings report on Wednesday, with adjusted earnings of $3.24, exceeding the consensus estimate of $2.82. Benzinga · Nov 5, 2025
Humana Medicare Advantage Crisis: Ratings Meltdown Puts Senior Healthcare at Risk Humana faces a Medicare Advantage crisis as downgraded star ratings threaten senior insurance coverage and reshape the 2026 healthcare market. International Business Times UK · Oct 15, 2025
Benzinga · Oct 14, 2025 Humana Loses Court Battle Over Medicare Advantage Ratings, Billions In Payments At Risk Humana Inc. (NYSE:HUM) lost a legal battle challenging cuts to its Medicare Advantage bonus payments, raising concerns over billions in potential revenue.
Kiplinger · Oct 8, 2025 Major Insurers Scale Back Medicare Advantage and Part D Plans for 2026 Beneficiaries enrolled in Medicare Advantage and Part D prescription drug plans might be losing their plan as UnitedHealthcare, Humana, and Aetna (CVS Health) scale back offerings for 2026.
Barchart · Sep 10, 2025 S&P 500 Climbs to a Record High on Fed Rate Cut Optimism The S&P 500 Index ($SPX ) (SPY ) today is up +0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.45%. September E-mini S&P futures (ESU25 ) are up +0.44%, and September E-mini Nasdaq futures...
Barchart · Sep 10, 2025 Stocks Supported as US Producer Prices Ease and Bond Yields Fall The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.27%. September E-mini S&P futures (ESU25 ) are up +0.46%, and September E-mini Nasdaq futures...
Barchart · Sep 10, 2025 Humana Stock: Is HUM Underperforming the Healthcare Sector? While Humana has notably underperformed the broader healthcare sector over the past year, it has outperformed recently, and analysts remain optimistic about the stock’s prospects.
Barchart · Sep 9, 2025 Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures...
Barchart · Aug 13, 2025 Are Wall Street Analysts Bullish on Humana Stock? While Humana stock seems to be regaining momentum lately, it is still underperforming the broader market, keeping analysts cautiously optimistic about its prospects.
Benzinga · Jul 30, 2025 Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.
Kiplinger · Jul 24, 2025 Humana to Cut Prior Authorizations for Medicare Advantage Plans by 2026 Humana, the second-largest provider of Medicare Advantage Plans, has pledged to streamline the often frustrating Prior Authorization process.
Fortune · Jul 23, 2025 'We must do better': Fortune 100 firm Humana slashes preapproval mandates in health insurance reform push Prior authorization is a process health insurers use to determine whether they will cover a prescription, medical procedure, or service.
Benzinga · Jul 22, 2025 Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals Humana Inc. NYSE: HUM) on Tuesday announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization.